226. Interstitial cystitis with Hunners ulcer
133 clinical trials,   151 drugs   (DrugBank: 46 drugs),   48 drug target genes,   137 drug target pathways

Searched query = "Interstitial cystitis with Hunners ulcer", "Interstitial cystitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02395042
(ClinicalTrials.gov)
April 15, 201517/3/2015A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's LesionsA Multicenter, Randomized, Double-blind, Placebo-controlled Study, Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis With Hunner's LesionsCystitis, Interstitial;UlcerDrug: LiRIS®;Drug: LiRIS PlaceboAllerganNULLCompleted18 YearsN/AFemale59Phase 2United States;Canada
2NCT01879683
(ClinicalTrials.gov)
July 201310/6/2013A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's LesionsA Phase 1b, Multicenter, Open Label Study Evaluating Safety, Tolerability and Preliminary Efficacy of LiRIS® 400 mg in Women With Ulcerative Interstitial CystitisChronic Interstitial CystitisDrug: LiRIS® 400 mgAllerganTARIS Biomedical, Inc.Completed18 YearsN/AFemale10Phase 1United States
3NCT01824303
(ClinicalTrials.gov)
March 201331/3/2013Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial CystitisA Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label ExtensionInterstitial CystitisDrug: LiRIS 400 mg;Other: LiRIS PlaceboAllerganTARIS Biomedical, Inc.Terminated18 YearsN/AFemale31Phase 2United States;Canada
4NCT01475253
(ClinicalTrials.gov)
November 20113/11/2011Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial CystitisA Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label ExtensionInterstitial CystitisDrug: Lidocaine Releasing Intravesical System - LiRIS®;Other: LiRIS Placebo;Procedure: Sham Cystoscopy ProcedureAllerganTARIS Biomedical, Inc.Terminated18 YearsN/AFemale104Phase 2United States;Canada